Craig Mooney leveraging 30 years’ industry experience to optimize eClinical trial technology delivery
Nottingham, England and Morrisville, NC – August 2, 2021 – Calyx, the eClinical and Regulatory solutions and services provider most relied on for solving complex data challenges in clinical research, today announced that Craig M. Mooney has joined the company as Vice President of Scientific E-tech Enabled Services. Mooney has nearly 30 years’ experience in the clinical development industry, with concentrated focus on optimizing IRT to improve clinical trial efficiencies.
Craig M. Mooney, VP, Scientific E-tech Enabled Services
“Craig brings a unique understanding of IRT from both a delivery and user perspective, which we believe will be a great benefit to our global pharmaceutical and CRO clients,” said Dr. Stephen Bravo, Chief Medical Officer of Calyx. “We’re delighted to have him join our team.”
Mooney comes to Calyx from Bristol-Myers Squibb, where he served as the Director of IRT for most of the past decade. In his role at Calyx, he will shape the company’s eClinical technology development pipeline and consult with its customers on optimizing IRT to improve operational efficiencies and meet study and regulatory requirements.
“Since Calyx became its own entity, I’ve watched them aggressively invest in hiring experts with well-honed skills and fresh viewpoints to ensure their solutions and services meet the needs of the industry,” said Mooney. “I see the company as the perfect blend of entrepreneurial creativity and the expertise that only comes with a long history of experience and success, and I’m thrilled to join the team.”
Visit Calyx.ai for more information.
About Calyx
Through innovative eClinical solutions and services, Calyx turns the uncertain into the reliable, helping bring new medical treatments to market faster. With deep expertise in clinical development and more than 25 years of supporting trial sponsors and clinical research organizations (CROs), Calyx harnesses that intelligence and activates its potential to solve complex problems, deliver fast insights, and get new drugs to market every day.
CTMS | EDC | IRT | Medical Imaging | RIM
Take your trials further, faster at calyx.ai, LinkedIn, Twitter, or Facebook.
Media Contact:
Christine Tobin | Christine.Tobin@calyx.ai |+1 412-628-8598
